awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48206271-0D4B5365-D76C-4717-9D92-35CDB345C49B
Q48206271-0D4B5365-D76C-4717-9D92-35CDB345C49B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48206271-0D4B5365-D76C-4717-9D92-35CDB345C49B
Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms.
P2860
Q48206271-0D4B5365-D76C-4717-9D92-35CDB345C49B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48206271-0D4B5365-D76C-4717-9D92-35CDB345C49B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
adcd0b06c54c962b59d714ea7b9271d615e5771c
P2860
An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients